CellCarta launches digital pathology and AI consortium for biomarker development
CellCarta, a global contract research organisation (CRO) laboratory serving the biopharmaceutical industry, has announced the formation of a Digital Pathology and AI Consortium intended to support biomarker discovery, patient stratification and companion diagnostic development across multiple disease areas.

